Citations (20)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (3)
Julie N Graff & Erin D Chamberlain. (2015) Sipuleucel-T in the treatment of prostate cancer: an evidence-based review of its place in therapy. Core Evidence 10, pages 1-10.
Read now
Read now
Daniel M Geynisman, Chun-Ru Chien, Fabrice Smieliauskas, Chan Shen & Ya-Chen Tina Shih. (2014) Economic evaluation of therapeutic cancer vaccines and immunotherapy: A systematic review. Human Vaccines & Immunotherapeutics 10:11, pages 3415-3424.
Read now
Read now
Nancy A Dawson & Erin E Roesch. (2014)
Sipuleucel-T and immunotherapy in the treatment of prostate cancer. Expert Opinion on Biological Therapy 14:5, pages 709-719.
Read now
Read now
Articles from other publishers (17)
Arunima Deb, Neel Patel, Palak A. Patel, Ekim Kilinc, Sana Hachem, Mohamad Elajami & Ephraim Mansour. 2024. Therapy Resistance in Prostate Cancer. Therapy Resistance in Prostate Cancer
235
253
.
Morgan E. Janes, Alexander P. Gottlieb, Kyung Soo Park, Zongmin Zhao & Samir Mitragotri. (2023) Cancer vaccines in the clinic. Bioengineering & Translational Medicine.
Crossref
Crossref
Samra Saleem, Abu B. Rashid, Sarma Shehzadi, Hassan Mumtaz, Muhammad Saqib, Anan Bseiso, Alexis V. Villasenor, Adeel Ahmed & Shamsun N. Sonia. (2023) Contemporaneous and upcoming trends in immunotherapy for prostate cancer: review. Annals of Medicine & Surgery 85:8, pages 4005-4014.
Crossref
Crossref
Felicia Maria Maselli, Francesco Giuliani, Carmelo Laface, Martina Perrone, Assunta Melaccio, Pierluigi De Santis, Anna Natalizia Santoro, Chiara Guarini, Maria Laura Iaia & Palma Fedele. (2023) Immunotherapy in Prostate Cancer: State of Art and New Therapeutic Perspectives. Current Oncology 30:6, pages 5769-5794.
Crossref
Crossref
Dirk Mehrens, Kristina K.M. Kramer, Lena M. Unterrainer, Leonie Beyer, Peter Bartenstein, Matthias F. Froelich, Fabian Tollens, Jens Ricke, Johannes Rübenthaler, Nina-Sophie Schmidt-Hegemann, Annika Herlemann, Marcus Unterrainer & Wolfgang G. Kunz. (2023) Cost-Effectiveness Analysis of 177Lu-PSMA-617 Radioligand Therapy in Metastatic Castration-Resistant Prostate Cancer. Journal of the National Comprehensive Cancer Network 21:1, pages 43-50.e2.
Crossref
Crossref
晓娟 吴. (2023) Antitumor Effects of Dendritic Cell Vaccine Modified by BCG HSP70 Gene in Vivo. Advances in Clinical Medicine 13:04, pages 6986-6992.
Crossref
Crossref
Mankgopo M. Kgatle, Tebatso M. G. Boshomane, Ismaheel O. Lawal, Kgomotso M. G. Mokoala, Neo P. Mokgoro, Nico Lourens, Kalevo Kairemo, Jan Rijn Zeevaart, Mariza Vorster & Mike M. Sathekge. (2021) Immune Checkpoints, Inhibitors and Radionuclides in Prostate Cancer: Promising Combinatorial Therapy Approach. International Journal of Molecular Sciences 22:8, pages 4109.
Crossref
Crossref
Claire L. Ihle & Philip Owens. (2020) Integrating the immune microenvironment of prostate cancer induced bone disease. Molecular Carcinogenesis 59:7, pages 822-829.
Crossref
Crossref
Sandra Santos-Sierra. (2020) Developments in anticancer vaccination: budding new adjuvants. Biological Chemistry 401:4, pages 435-446.
Crossref
Crossref
Daryl S. Spinner, Moira Ringo & Eric Faulkner. 2020. Second Generation Cell and Gene-based Therapies. Second Generation Cell and Gene-based Therapies
705
745
.
Adeline N. Boettcher, Ahmed Usman, Alicia Morgans, David J. VanderWeele, Jeffrey Sosman & Jennifer D. Wu. (2019) Past, Current, and Future of Immunotherapies for Prostate Cancer. Frontiers in Oncology 9.
Crossref
Crossref
Thomas Grochtdreis, Hans-Helmut König, Alexander Dobruschkin, Gunhild von Amsberg & Judith Dams. (2018) Cost-effectiveness analyses and cost analyses in castration-resistant prostate cancer: A systematic review. PLOS ONE 13:12, pages e0208063.
Crossref
Crossref
Yair Lotan & Ryan Hutchinson. 2018. Evidence‐Based Urology. Evidence‐Based Urology
53
58
.
Manuel Caitano Maia & Aaron R. Hansen. (2017) A comprehensive review of immunotherapies in prostate cancer. Critical Reviews in Oncology/Hematology 113, pages 292-303.
Crossref
Crossref
Marlena Janiczek, Łukasz Szylberg, Anna Kasperska, Adam Kowalewski, Martyna Parol, Paulina Antosik, Barbara Radecka & Andrzej Marszałek. (2017) Immunotherapy as a Promising Treatment for Prostate Cancer: A Systematic Review. Journal of Immunology Research 2017, pages 1-6.
Crossref
Crossref
Chiranjeev Sanyal, Armen G. Aprikian, Fabio L. Cury, Simone Chevalier & Alice Dragomir. (2016) Management of localized and advanced prostate cancer in Canada: A lifetime cost and quality-adjusted life-year analysis. Cancer 122:7, pages 1085-1096.
Crossref
Crossref
James D. Chambers, Michael J. Cangelosi & Peter J. Neumann. (2015) Medicare's use of cost-effectiveness analysis for prevention (but not for treatment). Health Policy 119:2, pages 156-163.
Crossref
Crossref